Navigation Links
BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
Date:7/3/2009

ficant potential in atopic dermatitis therapy. Based on our results, ProtoCure(TM) emulsion cream holds great promises in the treatment of inflammatory skin disorders."

Atopic dermatitis is a chronic inflammatory disease of the skin with an onset typically already in infancy. It affects up to 20 per cent of the general population in the Western countries, and the prevalence rate is rising. Atopic dermatitis may significantly impair the quality of life of those affected. Existing treatments often have undesirable side effects and do not always meet the needs of patients.

BioCis Pharma Ltd. is a Karolinska Development portfolio company.

BioCis Pharma Ltd is an innovative drug development company developing drug therapies based on a novel, patented therapeutic principles that target unmet medical needs in substantial therapeutic markets including inflammation, allergy, and cancer. The company's main investors are Karolinska Development AB (publ.), Finnish Industry Investment Ltd., and Etra Invest Ltd.

http://www.biocis.com

Contacts: Dr. Lasse Leino, CEO, BioCis Pharma Ltd., mobile phone +358-40-849-4694, lasse.leino@biocis.com


'/>"/>
SOURCE BioCis Pharma Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioCis Pharma Starts a Phase I Clinical Trial With a New Cancer Drug
2. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
3. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
4. Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints
5. Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
6. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
7. CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders
8. VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
9. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
10. Merz Pharmaceuticals Announce Three Studies of NT-201 - (Botulinum neurotoxin type A Free From Complexing Proteins)
11. DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 20, 2014   Coqui RadioPharmaceuticals Corp. ... first U.S. commercial producer of Molybdenum-99 (Mo-99), is proud ... INVAP to design its Medical Isotope Production ... Mo-99 is the parent isotope of Technetium-99, which is ... In 2012, Congress passed legislation making it a national ...
(Date:11/21/2014)... , Nov. 21, 2014  Lexicon Pharmaceuticals, Inc. ... has priced its offering of $80,000,000 aggregate principal amount ... Notes") in a private offering within the ... to qualified institutional buyers pursuant to Rule 144A under ... Act"). Lexicon has also granted the initial purchasers an ...
(Date:11/18/2014)... N.J. , Nov. 18, 2014 ... 230,000 American women this year who get a ... today announced new resources for case managers to ... and 5—to navigate the myriad physical, emotional and ... resources are available at no cost via the ...
Breaking Medicine Technology:Coqui RadioPharmaceuticals Inks Deal With INVAP 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 3New Breast Cancer Resources: Commission For Case Manager Certification Adds Specialty Tools to Case Management Body of Knowledge Online Learning Center 2
... in RA Signs and Symptoms Compared to ... Pharmaceuticals,Inc. (Nasdaq: TRBN ) today announced ... randomized, double-blind, placebo-controlled, multicenter,clinical trial of its ... results indicated that Trubion,s TRU-015 product candidate, ...
... Inc. (Nasdaq: TPTX ) today announced completion ... in clinical development for the,treatment of cognitive impairment ... muscarinic (M1) agonist, was found to be,safe and ... for four consecutive days. In two previous Phase ...
Cached Medicine Technology:Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 2Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 3Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 4Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 5TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia 2TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia 3
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- The cost of diabetes ... in recent years, climbing to more than $322 billion ... in cost were seen with prediabetes care, which have ... 82 percent, the researchers added. In 2012, excess ... more than $1,000 for every American. That total includes ...
(Date:11/21/2014)... MLF Biotech, Inc. has developed a probiotic ... Pets helps maintain digestive health and can assist in ... after it experiences a period of stress, dietary changes ... is a proprietary blend of pure probiotics with no ... strains that are safe and effective for both cats ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 Big Bud ... an upcoming episode of Innovations with Ed Begley Jr., ... show times TBA. , Big Bud Farms, growers of ... growing, harvesting, and utilization of medical marijuana. , This ... Bud Farms’ wide variety of products for medicating. Viewers ...
(Date:11/21/2014)... 21, 2014 Midway through the research ... Inc.’s (AIS) annual Directory of Health Plans, preliminary data ... Directory of Health Plans is a comprehensive resource with ... in the U.S. The 2015 edition will ... AIS’s Directory and Databases Division, the company’s exclusive in-house ...
(Date:11/21/2014)... 21, 2014 Recently, DressVe.com , a ... has announced a new collection of fashion accessories. Furthermore, the ... discounts, up to 95% off, on all its fashion items. ... According to the CEO of the company, their wedding dresses ... are now available at greatly discounted rates. , The ...
Breaking Medicine News(10 mins):Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2Health News:DressVe.com Announces Its 2014 Special Friday Sales 2
... Comprehensive Cancer Center, has been appointed by President Bush to the ... appointees named to the board on June 12, 2008. , The ... National Cancer Institute (NCI). The role of the board is ... Services and the director of the NCI on issues that ...
... provider based at The University of Queensland, and Q-Pharm, ... have formed a strategic alliance. , The alliance ... clients in the biotechnology and pharmaceutical industries. , ... the two businesses, which are both commercialisation enterprises of ...
... of Program Allows Verus to Focus Solely on AstraZeneca ... ... DIEGO, June 16 Verus Pharmaceuticals, Inc., a,pediatric-oriented specialty pharmaceutical ... pharmaceutical company, has,acquired its pediatric gastrointestinal development program. Included in,the ...
... Monthly for 9 Million ... Beneficiaries, ... of revenue cycle management and clinical communication,solutions, announced today that the ... of Defense (DoD) through the,Pharmacy Data Transaction Service (PDTS). Emdeon has ...
... Cardiva Medical, Inc., a,privately held medical device company ... it will present the initial market,results of the ... US,sales force expansion on June 18 at 3:20pm ... Medical Device Summit",medical technology investment and partnering conference ...
... Camp Bow Wow Doggy Campers Get a Campaign Bandana, ... Save their Dog from Cancer and other Diseases, ... fastest,growing premier doggy day and overnight camp, has launched ... (MAF), http://www.MorrisAnimalFoundation.org, and its campaign to cure dog ...
Cached Medicine News:Health News:TetraQ and Q-Pharm form strategic alliance 2Health News:TetraQ and Q-Pharm form strategic alliance 3Health News:Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma 2Health News:Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma 3Health News:Emdeon Business Services Processes One Billionth Pharmacy Claim for Department of Defense and the U.S. Military Health System 2Health News:Emdeon Business Services Processes One Billionth Pharmacy Claim for Department of Defense and the U.S. Military Health System 3Health News:Cardiva Medical, Inc. to Present at the 'Investment In Innovation (In3) Medical Device Summit' on June 18, 2008 in San Francisco, CA; Announces the Completion of Its Latest Phase in Its US Sales Force Expansion 2Health News:Camp Bow Wow(R) Launches Fundraising Effort to Help Cure Cancer in Dogs, via Morris Animal Foundation's Canine Cancer Campaign - Dogs Get Bandanas; Camp Bow Wow Locations in New Jersey Participating 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: